Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
August 21, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for November 8, 2005 Subscribe to this News Feed     Subscribe to this Podcast Feed  
 

Baptist Now Treating Lung Tumors with Cyberknife®

Baptist Cancer Services has treated a lung tumor with the CyberKnife® Stereotactic Radiosurgery System.
It also offered a more precise course of treatment with less normal lung affected and good chances for local control of his disease. He will also be receiving chemotherapy

Jackson, MS (PRWEB) November 8, 2005 -- Baptist Cancer Services, a division of Baptist Medical Center in Jackson, Miss., has treated a lung tumor with the CyberKnife® Stereotactic Radiosurgery System. Baptist Cancer Services will have the only system of this kind in the four-state area of Alabama, Arkansas, Mississippi and Louisiana.

Radiation oncologist Gregg Dickerson, M.D. treated the hospital's first lung case with the CyberKnife. Baptist's system is one of only 17 facilities in the world equipped with Synchrony, the equipment and software used with the CyberKnife making the kind of treatment this patient received possible.

Synchrony continuously adjusts the aiming of the x-ray beams from the CyberKnife's linear accelerator to match the motion of the tumor--dynamically and conformally--as the patient breathes during treatment. The first Baptist patient treated on the CyberKnife has Stage 1 non-small cell carcinoma but was not a surgical candidate because of medical conditions.

"Surgery would have been the best treatment for him," said Dr. Dickerson. "Standard radiation therapy and chemotherapy was the second best option. Quite a bit of lung would have been affected using standard techniques and equipment."

The treatment required that gold markers be inserted into the patient's body within and adjacent to the targeted tissue for alignment and tracking of the tumor during treatment. Then, the patient underwent a CT scan using thin slices. Using this information, Dr. Dickerson worked with Baptist's Medical Physicist Jeff Garrett to do treatment planning.

For this patient the CyberKnife allowed shorter, more convenient treatment-three sessions versus more than 30 and given over a one-week period instead of 6 to 7 weeks. "It also offered a more precise course of treatment with less normal lung affected and good chances for local control of his disease. He will also be receiving chemotherapy," adds Dr. Dickerson.

"Because so much less normal tissue is treated, higher doses can be given for each treatment resulting in much shorter courses of treatment," Dr. Dickerson explains. "This capability expands the options for the management of patients with early stage non-small cell lung cancer who are not surgical candidates.”

Contact:
Robby Channell
601-968-5135

# # #

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/U3VtbS1IYWxmLVNxdWEtSG9yci1TcXVhLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Robby Channell
Baptist Health Systems
601-968-5135
Email us Here
ATTACHED FILES

The Cyberknife room at Baptist Cancer Services was designed for the comfort of the patient and is equipped with surround sound and flat screen TV in the ceiling. This provides entertainment for the patient while being treated.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright